HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $68,500 | +183.7% | 88,216 | +9.7% | 0.00% | – |
| Q4 2022 | $24,145 | +201.8% | 80,403 | +361.9% | 0.00% | – |
| Q3 2022 | $8,000 | -46.7% | 17,407 | -32.1% | 0.00% | – |
| Q2 2022 | $15,000 | -68.8% | 25,640 | -31.7% | 0.00% | – |
| Q1 2022 | $48,000 | +14.3% | 37,563 | +1.1% | 0.00% | – |
| Q4 2021 | $42,000 | -22.2% | 37,141 | +6.0% | 0.00% | – |
| Q3 2021 | $54,000 | -70.0% | 35,036 | -61.5% | 0.00% | – |
| Q2 2021 | $180,000 | – | 91,106 | +197956.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 46 | -99.3% | 0.00% | – |
| Q4 2020 | $14,000 | – | 6,362 | +11681.5% | 0.00% | – |
| Q3 2020 | $0 | – | 54 | -37.2% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 86 | -89.6% | 0.00% | – |
| Q1 2020 | $1,000 | -94.7% | 823 | -76.6% | 0.00% | – |
| Q4 2019 | $19,000 | – | 3,519 | +7231.2% | 0.00% | – |
| Q3 2019 | $0 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 57,309 | $178,000 | 0.03% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 15,552 | $48,000 | 0.00% |
| Squarepoint Ops LLC | 15,524 | $48,000 | 0.00% |
| ExodusPoint Capital Management, LP | 11,632 | $36,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 33,215 | $103,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 57 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,786 | $49,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 29,233 | $91,000 | 0.00% |
| MORGAN STANLEY | 54 | $0 | 0.00% |